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ABSTRACT Picrotoxin (PTX) is a noncompetitive antagonist of many ligand-gated ion channels, with a site of action believed
to be within the ion-conducting pore. In the A-type gamma-aminobutyric acid receptor, a threonine residue in the second trans-
membrane domain is of particular importance for the binding of, and ultimate inhibition by, PTX. To better understand the
relationship between this residueand thePTXmolecule,wemutated this threonine residue to serine, valine, and tyrosine to change
the structural and biochemical characteristics at this location. The known subunit stoichiometry of the A-type gamma-aminobutyric
acid receptor allowed us to create receptors with anywhere from zero to ﬁve mutations. With an increasing number of mutated
subunits, eachaminoacid substitution revealedauniquepattern of changes inPTXsensitivity, ultimately encompassing sensitivity
shifts over several orders of magnitude. The electrophysiological data on PTX-mediated block, and supporting modeling and
docking studies, provide evidence that an interaction between the PTXmolecule and three adjacent uncharged polar amino acids
at this position of the pore are crucial for PTX-mediated inhibition.
INTRODUCTION
The A-type gamma-aminobutyric acid receptor (GABAAR)
belongs to the family of ligand-gated ion channels (LGIC),
which is also comprised of excitatory nicotinic acetylcholine
receptors (nAChR) and 5-hydroxytryptamine receptors, as
well as the inhibitory glycine and glutamate receptors. A
hallmark of this LGIC family is a pentameric arrangement of
subunits, with each subunit comprised of a large extracellular
N terminus, four transmembrane domains, a large intracellular
loop, and a small extracellular C terminus (1–7). There is
general agreement that the second transmembrane domain
(M2) from each of the ﬁve subunits lines the pore (8), although
other intracellularly located regions have been implicated in
ion conduction (9,10). The native GABAAR is composed of
several different subunits (a,b,g, d . . .) with the predominant
receptor being a1b2g2 at a subunit stoichiometry of 2:2:1
(11,12).
The GABAAR is a target for many classes of pharmaco-
logical compounds including benzodiazepines, barbiturates,
steroids, and noncompetitive antagonists (13). These noncom-
petitive antagonists include b-lactam antibiotics, t-buylbicy-
clophosphorothionate, insecticides, and picrotoxin (PTX).
PTX, which is a botanical convulsant, is an alkaloid com-
pound capable of blocking members of the LGIC family in-
cluding GABA, glycine, glutamate, 5-hydroxytryptamine,
and nACh receptors (14–18).
Numerous lines of evidence have led us to believe that PTX
binds in the pore of the GABAAR (17,19–21). Given that there
is no deﬁned structure for the pore-lining M2 region of the
GABAAR, much of what we know about M2 structure comes
from other LGIC family members. Investigations into the M2
of LGIC have suggested an a-helical structure with a slight
kink near the middle (22–25). Residues that are important for
the GABAAR chloride selectivity, as well as the other amino
acids of M2 that face the pore, have been identiﬁed (9,25).
Using the conventional numbering system, with the cyto-
plasmic end ofM2 being 19 and the extracellular side being 209
(26), residues that have been most often implicated in PTX
inhibition of the GABAAR are at the 29 and 69 positions.
Mutating these residues, particularly 69, can dramatically de-
crease the sensitivity of the GABAAR for PTX (19,27–30). In
addition, modeling studies that have docked PTX in the pore
support a role for the 69 ring in PTX inhibition (31,32). In this
study, we investigated the nature of the interaction between
PTX and the GABAAR by coexpression of wild-type and 69
mutant subunits. Due to the known stoichiometry and ar-
rangement of GABAAR subunits, each mutant receptor had
a unique assembly of zero to ﬁve mutant subunits. As the
number of mutated subunits was increased, there was a con-
comitant decrease in the sensitivity of the receptor for PTX.
Correlation of the electrophysiological data with homology
modeling and docking simulations suggests that a ring of
uncharged polar amino acids at the 69 level of the M2 trans-
membrane domain is a crucial component of PTX-mediated
inhibition. Furthermore, we favor a model in which PTX in-
teracts (via hydrogen bonds) with three adjacent residues, re-
sulting in a noncompetitive inhibition of the GABAAR.
METHODS
Mutagenesis, cloning, and in vitro transcription
Rat a1, b2, and g2 cDNA were subcloned into the pGEMHE vector (33).
Mutations a1T260S, a1T260V, and a1T260Y and g2T271S, g2T271V, and
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g2T271Y were generated using the overlap extension method (34). The
b2T256S, b2T256V, and b2T256Y mutations were introduced using the
QuickChange protocol (Stratagene, La Jolla, CA). All constructs were fully
veriﬁed by cDNA sequencing. cDNA was linearized with Nhe I (New
England BioLabs, Ipswitch, MA), and capped cRNA were transcribed from
linearized cDNA using the T7 mMessage mMachine Kit (Ambion, Austin,
TX). Integrity and yield of the cRNA were veriﬁed on a 1.0% agarose gel.
Xenopus oocyte expression
Female Xenopus laevis (Xenopus I, Ann Arbor, MI) were anesthetized with
0.2% 3-aminobenzoic acid ethyl ester, methanesulfonate salt. The ovarian
lobes were surgically removed from the frog and placed in a calcium-free,
oocyte Ringer’s 2 incubation solution. The oocyte Ringer’s 2 solution con-
sisted of 92.5 mMNaCl, 2.5 mMKCl, 1 mMMgCl2, 1 mMNa2HPO4, 5 mM
HEPES, 50 U/ml penicillin, and 50 mg/ml streptomycin at pH 7.5. The lobes
were then cut into smaller pieces and digested with 0.3% collagenase A
(Roche, Indianapolis, IN) while shaking for 1.5–2 h at room temperature. The
stage VI oocytes were selected and incubated at 18C before cRNA injection.
Micropipettes for cRNA injection were pulled from borosilicate glass
(Drummond Scientiﬁc, Broomall, PA) on a Sutter P87 horizontal puller and
their tips were cut with microscissors. The cRNA was injected into oocytes
with a Nanoject microinjection system (Drummond Scientiﬁc) at a total in-
jection volume of 40–70 nl (1mg/L). Injection ratios were 1:1:8 for a1:b2:g2,
respectively. This was done to ensure that all of the expressed receptors
contained the g2 subunit. Previous studies have shown that injecting a surplus
of the g2 cRNA does not alter the functional stoichiometry (11). For those
experiments involving the mixing of wild-type and mutant subunits (b and
bT69V or a and aT69V) we determined the ‘‘functionally equivalent’’
amount of cRNA to inject based on the maximum amplitude of the currents
after the receptors (i.e., abg versus abT69Vg) were expressed in oocytes. If
the expression levelswere different, the cRNAwas diluted and reinjected, and
the functional expression was again compared in oocytes. This was repeated
until the amount of expression was equal. Oocytes were injected with a
1:1:1:8 ratio of a:aT69V:b:g or a:b:bT69V:g to create a population where 25%
of the receptors would have two wild-type subunits, 25% would have two
mutant subunits, and 50% would have both one wild-type and one mutant
subunit. For each mixture experiment, we also injected the same amount of
wild-type andmutant cRNA into oocytes to be used as a ﬁnal correction factor
for any differences in the relative functional expression. Knowing the fraction
of current blocked by PTX for wild-type and double mutant receptors, we
were then able to subtract their dose-inhibition curves from the total inhibition
curve, thereby isolating the receptors with only one mutant subunit. This
analysis assumed that, in terms of PTX block, the position of the mutant
subunit within the pentameric receptor was inconsequential.
Voltage clamp of oocytes
We used two-electrode voltage-clamp procedures to record current two or
three days after cRNA injection. The experiments were performed using an
OpusXpress 6000A (Molecular Devices, Sunnyvale, CA). This system al-
lows for automated and simultaneous impalement and voltage clamp of an
octet of oocytes. The oocytes were perfused continuously with Ringer’s
solution containing 92.5 mM NaCl, 2.5 mM KCl, 5 mM HEPES, 1 mM
CaCl2, and 1 mMMgCl2 at pH 7.5. All experiments were performed at room
temperature. Recording microelectrodes were ﬁlled with 3M KCl, and their
resistances ranged from 0.5 to 1.5 Mv. Oocytes were clamped at 70 mV,
and agonist/antagonist–containing solutions were delivered from a 96-well
plate by disposable pipette tips, with a solution exchange time 0.5–1.0 s.
Data analysis
Agonist concentration-response relationships were ﬁt (least-squares) with a
sigmoidal equation as follows:
Activation I ¼ Imax
11 ðEC50=½AÞnH
(1)
in which I and Imax represent current at a given agonist concentration (A) and
maximal agonist-induced current, respectively. EC50 is the half-maximal
effective agonist concentration, and nH is the Hill coefﬁcient. For determi-
nation of the EC50, currents were measured at their peak amplitudes.
The IC50 (concentration of PTX, which decreased the agonist-mediated
current by 50%) for each receptor was determined by a least-squares ﬁt of the
relationship to the data as follows:
Inhibition I ¼ Imax
11 ð½PTX=IC50ÞnH
; (2)
where current I is a function of the inhibitor concentration, PTX. The IC50 for
PTX was obtained using the experimentally determined EC50 concentration
of GABA, and currents were sampled at the end of drug application. In a few
cases, the currents had not quite reached steady state. At our time resolution,
we were unable to distinguish if this was an incomplete block or incomplete
desensitization. In select data sets, we reanalyzed data and extrapolated (via
exponential ﬁts) to a plateau value for complete block. In no case did the IC50
values differ by more than 10% from the approach of simply measuring the
current at the end of the PTX application. Because we could not deﬁne the
relative contribution of desensitization to the current decays, it is not clear
which approach is more accurate. Regardless, this minor difference in the
sensitivity of PTX block (IC50) would not alter the general conclusions of this
study. All data are presented as mean 6 SE with nH indicating the Hill
coefﬁcient. Standard errors reported were derived from the independent ﬁts
of individual cells as opposed to the ﬁt for the averaged data. For some of the
T69Ymutant receptors, we were unable to inhibit 50% of the current; for this
reason, the recorded IC50 was extrapolated from the available data.
Structural modeling
Internal coordinates mechanism (ICM) software (Molsoft, La Jolla, CA) was
used to build a representation of the M2 region of the GABAA receptor. The
homologymodel was built byworking from the 4A˚ resolution structure of the
nAChR transmembrane domain (35). Alignments were constructed by pair-
ing GABA and nAChR subunits on the putative basis of their role in ligand
binding. In this model, the two GABAA a1 subunits correspond to nAChR
g and d, the two GABAA b2 subunits correspond to the two nAChR a-sub-
units, and the GABAA g2 subunit corresponds to the nAChR b-subunit (45).
The overall model was then energy-minimized to eliminate intrasubunit/in-
tersubunit clashes. After introducingmutations, further energyminimizations
conﬁrmed that these perturbations did not impart any instability to the M2
region. For the mutagenesis studies, models of each individual mutant were
made as described above and then combinedwith otherwild-type– ormutant–
modeled subunits. The energy would again be globally minimized and the 69
side chain positions were locally minimized to their environment.
Docking simulations
For docking simulations, we used the homology models created in the
manner described above. The resulting models were then run through the
ICM protocol to ﬁnd pockets that are probable drug binding sites. Of these
sites, only one site was located within the pore region. Residues around this
binding pocket were then analyzed for charge and hydrophobicity. Because
PTX is a mixture of picrotoxin and picrotin, and picrotoxinin is the more
potent compound at the GABAAR, we used a three-dimensional represen-
tation of a picrotoxinin molecule for all docking simulations. In the docking
simulations for mutant receptors, the PTX molecule originated in the ori-
entation found for the wild-type GABAAR but was not constrained during
subsequent energy minimizations. ICMMonte Carlo minimization protocols
were used, which ultimately provided information concerning PTX orien-
tation, binding energy (DG), and probable hydrogen-bond partners. Binding
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energies were derived from electrophysiologically determined IC50 values by
the relationship where R is the universal gas constant (8.31 JK-1mol1) and
T is the temperature in Kelvin as follows:
DG ¼ RT In½IC50: (3)
RESULTS
Pore-lining amino acids and PTX block
Fig. 1 shows an alignment of theM2 region of several GABA
and glycine subunits. Of particular interest is the residue at
the 6 position. In PTX-sensitive subunits, there is always an
uncharged polar threonine residue. Conversely, in subunits
that impart PTX resistance (Fig. 1, asterisk), there is a non-
polar methionine or phenylalanine residue. This suggests that
the hydrogen-bonding ability of the 69 residue may be a
feature of PTX-mediated inhibition.
To more directly address the issue of PTX-mediated in-
hibition, we mutated this 69 residue in each of the GABA a1,
b2, and g2 subunits to a serine, valine, or tyrosine residue.
Although serine and tyrosine residues contain a hydroxyl
group, this hydroxyl is in a different orientation than in the
naturally occurring threonine residue. Alternatively, the va-
line mutation has a very similar size to threonine but lacks the
hydroxyl group. These particular mutations were used to
investigate how the presence and position of a hydroxyl
group at the 69 level inﬂuences inhibition by PTX. In addi-
tion, due to the known stoichiometry and subunit arrange-
ment of GABAAR subunits, we could examine receptors with
zero to ﬁve mutations at this particular position.
Mutant agonist sensitivity
An EC50 was determined for all mutant receptors to ensure
that the 69 mutations did not have a deleterious effect on the
activation of the receptor (Fig. 2). Fig. 2 A shows GABA-
activated currents from oocytes expressing wild-type recep-
tors as well as receptors where all ﬁve 69 residues had been
mutated to serine, valine, or tyrosine. In Fig. 2 B, the con-
tinuous lines are ﬁts of the Hill equation (Eq. 1) to the dose-
response relationships, and yield EC50 values of 64.6 6 2.0
(n¼ 11), 81.36 7.4 (n¼ 12), 78.36 6.8 (n¼ 11), and 88.66
4.6 (n ¼ 11) for the wild-type, serine, valine, and tyrosine
mutants, respectively. Whereas a majority of the receptors
experienced no signiﬁcant difference in their EC50 forGABA,
only the aYbYgY receptor displayed a signiﬁcant shift in
GABA sensitivity (p . 0.05). EC50 values for all combina-
tions of mutations used in this study are provided in the Table
1. In addition to ensuring normal receptor function, determi-
nation of the EC50 for each combinationwas necessary, as this
concentration of GABA was used in the determination of the
IC50 for PTX.
69 mutations dramatically inﬂuence
PTX sensitivity
To determine the mutated receptors’ sensitivities to PTX, in-
creasing concentrations of PTXwere applied in the presence of
the EC50 concentration of GABA. As shown in Fig. 3 A,
GABA-mediated current was reduced by PTX in a dose-
dependent manner. Fig. 3 B shows a ﬁt of the data to Eq. 2 for
the wild-type receptor, as well as the case where all ﬁve of the
subunits carried a serine, valine, or tyrosine mutation at the 69
position. IC50 values for the conﬁgurations where all ﬁve
subunits have been mutated were 38.26 2.4 (n¼ 14), 3616
26 (n¼ 14), and 16146 48 (n¼ 11)mMfor the serine, valine,
and tyrosine mutants, respectively (Fig. 3 B and Table 1).
In the experiment discussed above, all ﬁve of the GABAAR
subunits were mutated. However, the a, b, and g-subunits,
which comprised the functional GABAAR, are in a 2:2:1 ratio
(11). If we coexpress mutants with wild-type subunits in
various combinations, we can examine how partial, rather
than comprehensive, adjustments of the biochemical envi-
ronment at the 69 level modulate inhibition by PTX.
PTX sensitivity is determined by the number of
mutated subunits
In the ﬁrst case, the 69 threonine was mutated to a serine
residue, maintaining the polar character of the side chain, but
likely altering the orientation of the hydroxyl group. The
Table 1 and Fig. 4 A, show that, as the number of T69S
mutations increases, there is a concomitant increase in the
IC50 for PTX. As the number of serines increases, there is an
apparent geometric increase in the IC50 ( Fig. 4 A, inset). In
addition, there are two possible combinations that produce
receptors with two mutant subunits (a- or b-subunits carry-
ing the mutation) and two possible combinations that pro-
duce receptors with three mutant subunits (a- and g- or
b- and g -subunits carrying the mutation). The fact that there
is no signiﬁcant difference between the IC50 values for the two
or three mutant combinations indicates that PTX sensitivity is
FIGURE 1 Sequence alignments of several subunits. Alignment of the
M2 domains of several ligand-gated ion channels including the rat GABA
a1, b2, g2, r1, r2 and glycine b1 subunits are shown. Subunits that impart
PTX resistance are indicated by asterisks. The 69 residue investigated in this
study is highlighted by the shaded box.
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determined by the number of mutated residues rather than the
identity (or position) of the subunit being mutated.
The T69V mutation (Fig. 4 B) removes a hydroxyl group
and results in a GABAAR that is much more resistant to in-
hibition by PTX compared to wild-type or serine mutants. Mu-
tating only one subunit (g) in the pentamer to valine has little
effect on sensitivity (p , 0.05), with an IC50 of only 4.2 6
2.1 mM (n¼ 17). This suggests that PTX does not require all
ﬁve 69 residues for inhibition. However, if two or more res-
idues are mutated to valine, we observe a dramatic increase in
the IC50 for PTX. As with the serine mutations, PTX sensi-
tivity was determined by the number of subunits mutated. For
example, the a mutation on its own exhibited an IC50 of
126 6 7.5 mM (n ¼ 13), and the b mutation on its own ex-
hibited an IC50 of 148 6 12 mM (n ¼ 11).
Mutation of the 69 residue to a large aromatic residue that
still has a hydroxyl group, was accomplished with a tyrosine
substitution. In a previous study, we established that the in-
sertion of a large nonpolar 69 residue (phenylalanine) com-
pletely abolished PTX sensitivity (19), and that the insertion
of only one of these residues was sufﬁcient to make the
GABAAR resistant to PTX (28). The Table 1 and Fig. 4 C
shows that the tyrosine mutation has the same dominant
negative effect, despite the fact that it is a potential hydrogen-
bonding partner. That is, even a single substitution at the 69
position imparts near PTX resistance.
Mutation of only one subunit (g) to valine resulted in a
minor increase in IC50, whereas mutation of two subunits (a
or b) increased the IC50 by nearly two orders of magnitude.
Our working hypothesis, which will be considered in the
FIGURE 2 GABA sensitivities of mutant receptors. (A)
Representative traces of GABA-induced currents for the
wild-type GABA receptor and the three different mutations
examined in this study. In this case, all subunits carry the
indicated mutation; serine (S), valine (V), or tyrosine (Y). (B)
The GABA dose-response relationship for the wild-type
receptor (open circles), as well as the receptors where all
ﬁve subunits were mutated to serine (solid circles), valine
(squares), or tyrosine (diamonds). The continuous lines are
ﬁts of the Hill equation (Eq. 1) to the dose-response relation-
ships of the peak current and yielded EC50 values of 64.66
2.2, 81.3 6 7.5, 81.3 6 6.9, and 88.7 6 4.7 mM for wild-
type, T69S, T69V, andT69Y, respectively. This poremutation
did not signiﬁcantly alter the sensitivity of the receptor to
GABA.
TABLE 1 Characterization of mutant GABAARs
Receptor EC50 (GABA) IC50 (PTX)
a b g n EC50 nH n IC50 nH n
Wt Wt Wt 0 64.6 6 2.2 1.8 6 0.2 11 0.8 6 0.1 1.1 6 0.1 11
Wt Wt S 1 57.5 6 9.3 1.7 6 0.1 10 3.2y 6 1.9 0.9 6 0.2 11
S Wt Wt 2 78.8 6 8.6 1.5 6 0.3 8 7.3 6 1.7 0.8 6 0.1 12
Wt S Wt 2 58.1 6 3.5 1.6 6 0.3 10 5.0 6 1.4 1.3 6 0.1 13
S Wt S 3 51.2 6 6.6 1.8 6 0.1 9 11.1 6 2.1 0.7 6 0.3 14
Wt S S 3 51.1 6 5.1 2.1 6 0.2 11 8.01 6 2.1 0.9 6 0.1 12
S S Wt 4 61.0 6 6.2 1.8 6 0.1 8 21.3 6 1.2 1.0 6 0.2 16
S S S 5 81.3 6 7.4 1.7 6 0.1 12 38.2 6 2.4 1.1 6 0.4 14
Wt Wt V 1 65.5 6 5.4 2.2 6 0.2 11 4.2y 6 2.1 1.2 6 0.4 17
V Wt Wt 2 74.3 6 9.6 1.9 6 0.1 12 126 6 7.5 1.3 6 0.3 13
Wt V Wt 2 63.3 6 8.0 1.7 6 0.2 13 148 6 12 1.0 6 0.1 11
V Wt V 3 77.3 6 7.1 2.1 6 0.1 11 184 6 18 1.3 6 0.3 14
Wt V V 3 81.3 6 4.4 1.6 6 0.3 9 191 6 11 1.4 6 0.2 11
V V Wt 4 78.2 6 5.6 1.9 6 0.1 12 242 6 16 0.8 6 0.1 12
V V V 5 78.3 6 6.8 1.6 6 0.3 11 361 6 26 1.2 6 0.3 14
Wt Wt Y 1 52.2 6 5.5 2.3 6 0.2 10 1339 6 39 1.6 6 0.2 10
Y Wt Wt 2 54.2 6 5.1 2.1 6 0.4 9 1605 6 31 1.3 6 0.4 9
Wt Y Wt 2 51.5 6 4.7 1.8 6 0.1 8 1544 6 46 1.4 6 0.3 11
Y Wt Y 3 61.8 6 9.3 1.9 6 0.2 11 1594 6 55 1.6 6 0.3 12
Wt Y Y 3 77.6 6 6.0 1.7 6 0.2 11 1533 6 64 1.7 6 0.2 14
Y Y Wt 4 81.2 6 6.9 1.6 6 0.1 10 1636 6 41 1.4 6 0.3 14
Y Y Y 5 88.6* 6 4.6 1.9 6 0.2 11 1614 6 48 1.8 6 0.2 11
The left column indicates the subunit composition used as well as the total number of mutant subunits in that receptor.
*Denotes a signiﬁcant difference in EC50 as tested by the Student’s t-test (p , 0.05).
yIndicates a lack of signiﬁcant difference in the IC50 from the wild-type (p . 0.05).
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Discussion, predicts that any single subunit carrying the va-
line mutation will demonstrate a modest decrease in PTX
sensitivity comparable to that observed for the g-subunit.
Owing to the 2:2:1 stoichiometry of the a1b2g2 GABA
receptor, the only straightforward method for expressing a
GABA receptor with a single mutation is to mutate the
g-subunit. To circumvent this limitation, we devised the
following strategy for determining PTX IC50 values for
GABA receptors containing a single mutant a-subunit or a
single mutant b-subunit. Brieﬂy, this was achieved by mix-
ing equivalent amounts of wild-type and mutant cRNA (a
and aT69V, for example) with wild-type b and g. Ignoring
subunit order, this results in a heterogeneous population of
receptors of which 25% are all wild-type, 25% are all mutant,
and the remaining 50% contain a single wild-type and a
single mutant a-subunit. Since the PTX sensitivity of the all
wild-type and all mutant receptors is known, we can subtract
their scaled (see Methods) dose-inhibition relationships from
that of the total curve. This leaves the dose-inhibition rela-
tionship of the remaining sub-population, that containing a
single wild-type and single mutant a-subunit. The same can
be accomplished for the b-subunit.
Fig. 5 shows the dose-inhibition relationship for the wild-
type (open circles), the extracted dose-inhibition relation-
ships determined for the single a and the single b-mutant
subunits (open and solid squares) along with that of the
g-mutant (gray squares). As was true for the g-mutant, the
PTX sensitivity of the singly mutant a- and b-subunit was
only modestly increased with IC50 values of 9.2 6 2.8 mM
(n¼ 7) and 12.26 3.4 mM (n¼ 5), respectively. These IC50
values are plotted as open circles in Fig. 4 B. These data
support the observation derived from the g-mutant studies—
only a modest shift in IC50 is observed when a single subunit
carried the valine mutation.
DISCUSSION
Our goal in this study was to examine the PTX-mediated in-
hibition of the GABAAR and, in particular, how the nature of
the amino acid at the 69 level inﬂuences PTX inhibition. Be-
cause the GABAAR is a heteromeric pentamer, with a ﬁxed
stochiometry, we could examine subtle changes in PTX
sensitivity as the number of mutated residues was increased
from zero to ﬁve. We interpret these changes in sensitivity as
being due to the repositioning, or elimination, of hydroxyl
groups attached to the 69 residue in the pore.
Docking of PTX within the GABAA receptor pore
In an attempt to rationalize the shifts in IC50 with the under-
lying structural changes,we constructed a homologymodel of
the wild-type GABAAR into which a PTX molecule could be
docked. This docking simulation was restricted to the cyto-
plasmic region of the GABAAR pore (residues 29–99). As
FIGURE 3 Determination of the IC50 for picrotoxin. (A)
GABA-activated currents (using an EC50 concentration of
GABA) in the presence of increasing concentrations of
PTX are shown. Note that the mutations imparted varying
amounts of picrotoxin resistance. (B) The PTX inhibition
relationship for wild-type receptors (open circles), as well
as the receptors where all ﬁve subunits had been mutated to
serine (solid circles), valine (squares), or tyrosine (dia-
monds) are shown. The continuous lines are ﬁts of Eq. 2 to
the dose-response relationships. This yielded IC50 values of
0.8 6 0.1, 38.3 6 2.5, 361 6 26, and 1614 6 48 for wild-
type, T69S, T69V, and T69Y, respectively. For these exper-
iments, current measurements were made at the end of
agonist-antagonist application.
FIGURE 4 Relationship between the IC50
for picrotoxin and the number of 69 muta-
tions. Graphs are shown for the (A) serine
mutation, (B) valine mutation, and (C) tyro-
sine mutation. The solid lines in all three
graphs simply connect the symbols, except
for the inset in the serine graph where a linear
regression was performed on a semilogarith-
mic plot of the data. In the case of serine, each
additional mutation produced an approximate
twofold increase in the IC50. Note how, in the
case of valine, one mutation produced very
little change in PTX sensitivity. (B) The open
circles denote receptors with only one mutant
a- or b-subunit.
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shown in Fig. 6, the PTXmolecule is preferentially docked in
the vicinity of the 69 residue. In its ideal docked location, the
PTXmolecule’s oxygen-containing groups form at least three
hydrogen bonds with three adjacent 69 threonines. The iso-
propyl group is situated toward the cytoplasmic side of the
pore, where it may interact with amino acids at the 29 level
(31,32).
Correlation of electrophysiological and
modeling data
The mutations changed the amino acid side chain at the 69
residue, which the homology model and docking simulations
suggest to be a key structural component for PTX inhibition.
To further investigate how these mutations affected the in-
teraction of PTX with pore-lining residues, homology mod-
els were constructed for each mutant receptor, and docking
simulations were carried out in each case.
To correlate our experimental and modeling data, the IC50
values were converted into free energy of binding (DG) by
Eq. 3 (Table 1). Fig. 7 displays the lowest energy of binding
for different numbers of serine and valine mutations, as de-
termined both experimentally (symbols) and through docking
simulations (lines). Fig. 7 shows that mutating the 69 ring
from threonine to serine produced relatively modest effects,
causing only a small reduction in the free energy of binding
(Fig. 7, circles). For this T69S mutation, the docking simu-
lations predicted a similar modest progression in DG (Fig. 7,
solid line). In the case of the T69V mutations, we observed a
steeper decrease in binding energy (Fig. 7, squares) as each
threonine was replaced in the 69 ring. This decrease in DG
corresponds well with the energies determined by the dock-
ing simulations (Fig. 7, dashed line). Lastly, it should be
noted that, in both the experimental data and predictions from
the docking, the valine mutation in only one subunit has little
effect on inhibition by PTX. Due to the presumed steric
hindrance, energies of binding were not calculated for the
T69Y mutants.
Mechanism of PTX-mediated inhibition
For both the serine and valine mutants, there was only a very
modest change in the IC50 for PTX when only one residue
was mutated. This implies that the removal of only one 69
threonine has little to no effect on PTX sensitivity. In addi-
tion, docking simulations of PTX into GABAARs with only
one mutant subunit (Fig. 7) suggest only a modest reduction
in binding energy compared to the wild-type receptor. Due to
the subunit arrangement of the GABAAR, the mutation of the
a- or b-subunit creates a receptor that no longer has three
adjacent wild-type residues. Only the wild-type or g-mutant
receptor has three adjacent wild-type residues. We therefore
devised an approach that would allow us to infer the PTX
sensitivity of receptors containing only one mutant a-subunit
or one mutant b-subunit based on wild-type and mutant co-
expression. In these two cases, similar to the g-subunit mu-
tation, there was only a modest decrease in PTX sensitivity.
FIGURE 5 Dose-inhibition relationship for single subunit mutations for
PTX. The open circles plot the picrotoxin-mediated antagonism of the wild-
type receptor. Due to the 2:2:1 stoichiometry of the a1b2g2 GABA
receptor, mutation of g and coexpression with its wild-type counterparts
produce a receptor with a single 69 mutation. To examine the sensitivity of
PTX block of receptors with a single mutant a or single mutant b-subunit,
mixing studies were performed in which the wild-type and mutant a-subunit
(for example) was mixed in equal ratios and expressed with wild-type b and
g. Because the sensitivity of block for the wild-type and double mutant
combinations is known, their inhibition curves can be subtracted from the
total heterogenous population of receptors (see Methods) leaving the dose-
inhibition curve for the singly mutant combination. Note the similarity of the
PTX sensitivity regardless of the particular subunit carrying the mutation.
The IC50 values for PTX antagonism were 9.26 2.8 mM (n¼ 7), 12.26 3.4
mM (n ¼ 5), and 4.2 6 2.1 (n ¼ 17) for a, b, and g, respectively.
FIGURE 6 PTX molecule docked in the GABAAR pore.
(A) Extracellular view of docking simulation carried out on
a homology model of the GABAAR M2 domain composed
of a1 (red), b2 (blue), and g2 (green) subunits. Predicted
hydrogen bonds are displayed as green dashes. (B) Side
view of a PTX molecule docked at the 69 level.
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In the wild-type receptor, there are ﬁve possible adjacent
triplets that can interact with PTX. With a single mutant
subunit, the potential number of adjacent triplets decreases to
two. This reduction in the number of potential binding ori-
entations might account for the signiﬁcant, albeit modest,
decrease in PTX sensitivity with a single mutant subunit.
Nevertheless, these functional data are consistent with the
docking studies that propose the PTXmolecule preferentially
interacts with three adjacent subunits (Fig. 6).
As the number of hydroxyl groups was reduced, the for-
mation of GABAAR-PTX interactions became less energet-
ically favorable. This is evident when examining both the
docking and IC50 data, and suggests an alteration in receptor
kinetics. Although there were apparent differences in the
decay toward steady state with PTX inhibition, the question
of changes in PTX association versus dissociation rates is
heavily confounded by the concomitant GABAAR desensi-
tization. An experimental system that allows for rapid solu-
tion exchange (e.g., macropatches) would be required for a
rigorous kinetic analysis of PTX inhibition.
The T69VGABAARs maintained some sensitivity to PTX,
even when all ﬁve of the subunits were mutated. We attribute
this to the fact that PTX was still able to reach, and interact,
with secondary binding sites, most likely the 29 residues,
where hydrophobic interactions have been shown to play
a role in stabilizing the PTX molecule in the pore
(20,31,32,36,37). However, for the T69Ymutations, it seems
very unlikely that a molecule the size of PTX would be able
to penetrate through the ring of tyrosines to the 29 level.
Therefore, the inhibition seen at higher PTX concentrations
might be due a low afﬁnity component of PTX inhibition at
some other site, as has been described (38).
Previously, our lab has demonstrated that the presence of
a single phenylalanine residue at the 69 position could elimi-
nate PTX sensitivity (19,29). It was unclear, however, if this
resistance to PTX inhibition was due to a steric hindrance or
the lack of a hydroxyl group for hydrogen bonding. These
results clarify this issue in that, despite having a hydroxyl
group, a large aromatic residue (tyrosine) at the 69 position
inhibits the binding of PTX. The tyrosine residues, similar to
the phenylalanine, most likely prevent PTX inhibition by
forming a physical barrier, not allowing the molecule to
penetrate the pore and reach its binding site.
Although residues discussed in this study are found deep
within the pore of the GABAAR, our results do not neces-
sarily conﬁrm the idea that PTX is acting as a pore-blocker
(16,17). PTX has also been labeled a mixed (competitive and
noncompetitive) antagonist (39–42) and an allosteric mod-
ulator that acts to stabilize the closed or desensitized state
(42–45). Further support of an allosteric mechanism is be-
yond the scope of this study. However, the fact that the 69
residue is cytoplasmic to the proposed 99 gate of the GABA
receptor (46) provides an explanation for the observed use-
dependence in the PTX block of the GABAAR. In addition, it
is difﬁcult to imagine a scenario in which the presence of an
ellipsoid PTX molecule with a major diameter of ;5.4 A˚,
within a region of the pore that narrows to 7.2 A˚, could allow
for the permeation of any ion species. It is for this reason that
we propose a model in which the PTX molecule is stabilized
by three adjacent 69 residues, inhibiting ion ﬂow through a
noncompetitive, pore-blocking mechanism.
REFERENCES
1. Cully, D. F., D. K. Vassilatis, K. K. Liu, P. S. Paress, L. H. Van der
Ploeg, J. M. Schaeffer, and J. P. Arena. 1994. Cloning of an avermectin-
sensitive glutamate-gated chloride channel from Caenorhabditis elegans.
Nature. 371:707–711.
2. Grenningloh, G., A. Rienitz, B. Schmitt, C. Methfessel, M. Zensen, K.
Beyreuther, E. D. Gundelﬁnger, and H. Betz. 1987. The strychnine-
binding subunit of the glycine receptor shows homology with nicotinic
acetylcholine receptors. Nature. 328:215–220.
3. Maricq, A. V., A. S. Peterson, A. J. Brake, R. M. Myers, and D. Julius.
1991. Primary structure and functional expression of the 5HT3 recep-
tor, a serotonin gated ion channel. Science. 254:432–436.
4. Noda, M., H. Takahashi, T. Tanabe, M. Toyosato, Y. Furutani, and T.
Hirose. 1982. Primary structure of a subunit precursor of Torpedo
californica acetylcholine receptor deduced from cDNA sequence.
Nature. 299:793–797.
5. Qian, H., and J. Dowling. 1994. Pharmacology of novel GABA
receptors found on rod horizontal cells of the white perch retina.
J. Neurosci. 14:4299–4307.
6. Schoﬁeld, P. R., M. G. Darlison, N. Fujita, D. R. Burt, F. A.
Stephenson, H. Rodriguez, L. M. Rhee, J. Ramachandran, V. Reale,
T. A. Glencorse, P. H. Seeburg, and E. A. Barnard. 1987. Sequence
and functional expression of the GABAA receptor shows a ligand-gated
receptor superfamily. Nature. 328:221–227.
FIGURE 7 PTX binding energy at the 69 level. The symbols are the
experimentally determined free energy of binding of PTX versus the number
of 69 residues that carry the particular mutation. These free energies were
calculated from the IC50 values using Eq. 3. The T69S mutation (circles) had
a less disruptive effect on PTX binding than that of the T69V mutation
(squares). The predicted value of the binding energy from the docking
studies is illustrated by the solid (serine) and dashed (valine) lines. Although
the experimental and predicted values are shifted somewhat, the pattern of
the relationships are similar. Also note that the modeling and electrophys-
iological studies demonstrate a near lack of an effect of a single valine
substitution.
Picrotoxin Block of GABAA Receptors 4305
Biophysical Journal 94(11) 4299–4306
7. Davies, P. A., W. Wang, T. G. Hales, and E. W. Kirkness. 2003. A
novel class of ligand gated ion channel is activated by Zn21. J. Biol.
Chem. 278:712–717.
8. Leonard, R. J., C. G. Labarca, P. Charnet, N. Davidson, and H. A.
Lester. 1988. Evidence that the M2 membrane-spanning region lines
the ion channel pore of the nicotinic receptor. Science. 242:1578–1581.
9. Filippova, N., V. E. Wotring, and D. S. Weiss. 2004. Evidence that the
TM1–TM2 loop contributes to the r1 GABA receptor pore. J. Biol.
Chem. 279:20906–20914.
10. Kelley, S. P., J. I. Dunlop, E. F. Kirkness, J. J. Lambert, and J. A.
Peters. 2003. A cytoplasmic region determines single-channel conduc-
tance in 5-HT3 receptors. Nature. 424:321–324.
11. Chang, Y. C., R. Wang, S. Barot, and D. S. Weiss. 1996. Stoichiometry
of a recombinant GABAA receptor. J. Neurosci. 16:5415–5424.
12. McKernan, R. M., and P. J. Whiting. 1996. Which GABAA-receptor
subtypes really occur in the brain? Trends Neurosci. 19:139–143.
13. Cascio, M. 2006. Modulating inhibitory ligand-gated ion channels.
AAPS J. 8:353–361.
14. Dong, C. J., and F. S. Werblin. 1996. Use-dependent and use-
independent blocking actions of picrotoxin and zinc at the GABAC
receptor in retinal horizontal cells. Vision Res. 36:3997–4005.
15. Das, P., C. L. Bell-Horner, T. K. Machu, and G. H. Dillon. 2003. The
GABAA receptor antagonist picrotoxin inhibits 5-hydroxytryptamine
type 3A receptors. Neuropharmacology. 44:431–438.
16. Etter, A., D. F. Cully, K. K. Liu, B. Reiss, D. K. Vassilatis, J. M.
Schaeffer, and J. P. Arena. 1999. Picrotoxin blockade of invertebrate
glutamate-gated chloride channels: subunit dependence and evidence
for binding within the pore. J. Neurochem. 72:318–326.
17. Inoue, M., and N. Akaike. 1988. Blockade of g-aminobutyric acid-
gated chloride current in frog sensory neurons by picrotoxin. Neurosci.
Res. 5:380–394.
18. Erkkila, B. E., D. S. Weiss, and V. E. Wotring. 2004. Picrotoxin-me-
diated inhibition of the nicotinic a3b4 and a7 receptors. Neuroreport.
129:47–53.
19. Gurley, D., J. Amin, P. C. Ross, D. S. Weiss, and G. White. 1995. Point
mutations in the M2 region of the a, b or g subunit of the GABAA
channel that abolish block by picrotoxin. Receptors Channels. 3:13–20.
20. Ffrench-Constant, R. H., T. A. Rocheleau, J. C. Steichen, and A. E.
Chalmers. 1993. A point mutation in a Drosophila GABA receptor
confers insecticide resistance. Nature. 363:449–451.
21. Enz, R., and J. Bormann. 1995. A single point mutation decreases
picrotoxinin sensitivity of the human GABA receptor r1 subunit.
Neuroreport. 6:1569–1572.
22. Akabas, M. H., C. Kauffmann, P. Archdeacon, and A. Karlin. 1994.
Identiﬁcation of acetylcholine receptor channel lining residues in the
entire M2 segment of the a subunit. Neuron. 13:919–927.
23. Reeves, D. C., E. N. Goren, M. H. Akabas, and S. C. Lummis. 2001.
Structural and electrostatic properties of the 5-HT3 receptor pore
revealed by substituted cysteine accessibility mutagenesis. J. Biol.
Chem. 276:42035–42042.
24. Xu, M., and M. H. Akabas. 1993. Amino acids lining the channel of
the g-aminobutyric acid type A receptor identiﬁed by cysteine substi-
tution. J. Biol. Chem. 268:21505–21508.
25. Xu, M., and M. H. Akabas. 1996. Identiﬁcation of channel-lining
residues in the M2 membrane-spanning segment of the GABA(A)
receptor a1 subunit. J. Gen. Physiol. 107:195–205.
26. Lester, H. A. 1992. The permeation pathway of neurotransmitter-gated
ion channels. Annu. Rev. Biophys. Biomol. Struct. 21:267–292.
27. Pribilla, I., T. Takagi, D. Langosch, J. Bormann, and H. Betz. 1992. The
atypical M2 segment of the b subunit confers picrotoxinin resistance to
inhibitory glycine receptor channels. EMBO J. 11:4305–4311.
28. Das, P., and G. H. Dillon. 2005. Molecular determinants of picrotoxin
inhibition of 5-hydroxytryptamine type 3 receptors. J. Pharmacol. Exp.
Ther. 314:320–328.
29. Sedelnikova, A., B. E. Erkkila, H. Harris, S. O. Zakharkin, and D. S.
Weiss. 2006. Stoichiometry of a pore mutation that abolishes picro-
toxin-mediated antagonism of the GABAA receptor. J. Physiol.
577:569–577.
30. Zhang, D., Z. H. Pan, A. D. Brideau, and S. A. Lipton. 1995. Cloning
of a g-aminobutyric acid type C receptor subunit in rat retina with a
methionine residue critical for picrotoxinin channel block. Proc. Natl.
Acad. Sci. USA. 92:11756–11760.
31. Chen, L., K. A. Durkin, and J. E. Casida. 2006. Structural model for
g-aminobutyric acid receptor noncompetitive antagonist binding: widely
diverse structures ﬁt the same site. Proc. Natl. Acad. Sci. USA. 103:
5185–5190.
32. Zhorov, B. S., and P. D. Bregestovski. 2000. Chloride channels of
glycine and GABA receptors with blockers: Monte Carlo minimization
and structure-activity relationships. Biophys. J. 78:1786–1803.
33. Liman, E. R., J. Tytgat, and P. Hess. 1992. Subunit stoichiometry of a
mammalian K1 channel determined by construction of multimeric
cDNAs. Neuron. 9:861–871.
34. Kammann, M., J. Laufs, J. Schell, and B. Gronenborn. 1989. Rapid
insertional mutagenesis of DNA by polymerase chain reaction (PCR).
Nucleic Acids Res. 17:5404.
35. Miyazawa, A., F. Yoshinori, and N. Unwin. 2003. Structure and gating
mechanism of the acetylcholine receptor pore. Nature. 423:949–955.
36. O’Mara, M., B. Cromer, M. Parker, and S. Chung. 2005. Homology
model of the GABAA receptor examined using Brownian dynamics.
Biophys. J. 88:3286–3299.
37. Xu, M., D. F. Covey, and M. H. Akabas. 1995. Interaction of
picrotoxin with GABAA receptor channel-lining residues probed in
cysteine mutants. Biophys. J. 69:1858–1867.
38. Smart, T. G., and A. Constanti. 1986. Studies on the mechanism of
action of picrotoxinin and other convulsants at the crustacean muscle
GABA receptor. Proc. R. Soc. Lond. B. Biol. Sci. 227:191–216.
39. Constanti, A. 1978. The ‘mixed’ effect of picrotoxin on the GABA
dose/conductance relation recorded from lobster muscle. Neurophar-
macology. 17:159–167.
40. Yoon, K., D. Covey, and S. Rothman. 1993. Multiple mechanisms of
picrotoxin block of GABA-induced currents in rat hippocampal neu-
rons. J. Physiol. 464:423–439.
41. Dillon, G. H., W. B. Im, D. B. Carter, and D. D. McKinley. 1995.
Enhancement by GABA of the association rate of picrotoxin and tert-
butylbicyclophosphorothionate to the rat cloned a1b2g2 GABAA
receptor subtype. Br. J. Pharmacol. 115:539–545.
42. Krishek, B. J., S. J. Moss, and T. G. Smart. 1996. A functional
comparison of the antagonists bicuculline and picrotoxin at recombi-
nant GABAA receptors. Neuropharmacology. 35:1289–1298.
43. Ikeda, T., K. Nagata, T. Shono, and T. Narahashi. 1998. Dieldrin and
picrotoxinin modulation of GABAA receptor single channels. Neuro-
report. 9:3189–3195.
44. Shan, Q., J. L. Haddrill, and J. W. Lynch. 2001. A single b subunit M2
domain controls the picrotoxin sensitivity of ab heteromeric glycine
receptor chloride channels. J. Neurochem. 76:1109–1120.
45. Porter, N. M., T. P. Angelotti, R. E. Twyman, and R. L. Macdonald.
1992. Kinetic properties of a1b1 g-aminobutyric acid A receptor
channels expressed in Chinese hamster ovary cells: regulation by
pentobarbital and picrotoxin. Mol. Pharm. 42:872–881.
46. Chang, Y., and D. S. Weiss. 1998. Substitutions of the highly
conserved M2 leucine create spontaneously opening r1 g-aminobutyric
acid receptors. Mol. Pharm. 53:511–523.
4306 Erkkila et al.
Biophysical Journal 94(11) 4299–4306
